Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (4): 392-395.DOI: 10.3969/j.issn.1673-8640.2022.04.018

Previous Articles     Next Articles

Research status of Actinotignum schaalii

SHANG Xipeng, LI Sha, DU Jinghui, LIU Xu   

  1. Department of Clinical Laboratory,the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion Tianjin 300380,China
  • Received:2020-04-27 Revised:2020-09-10 Online:2022-04-30 Published:2022-06-07

Abstract:

Actinotignum schaalii is facultative anaerobic Gram-positive Actinobacillus. With the improvement of clinical laboratory culture conditions and the wide usage of matrix-assisted laser desorption ionization time-of-flight mass spectrometry(MALDI-TOF MS),the detection rate of Actinotignum schaalii is increasing,and it is found that it is closely related to urinary tract infection. It is not sensitive to antibiotics commonly used,such as co-trimoxazole and quinolone,in the treatment of urinary tract infection,and it is sensitive to beta-lactamase. Actinotignum schaalii is a novel pathogen of urinary tract infection,and there has been no report on Actinotignum schaalii in China. In order to better understand Actinotignum schaalii,this review summarizes and expounds relevant reports abroad.

Key words: Actinotignum schaalii, Urinary tract infection, Anti-infection treatment

CLC Number: